BG Medicine, Inc. (BGMD)
Stock Price: $0.1460 USD
-0.0040 (-2.67%)
Updated Feb 23, 2021 3:48 PM EST - Market closed
| Market Cap | 535,049 |
| Revenue (ttm) | 1.57M |
| Net Income (ttm) | -6.96M |
| Shares Out | 11.37M |
| EPS (ttm) | -0.72 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 23 |
| Last Price | $0.1460 |
| Previous Close | $0.1500 |
| Change ($) | -0.0040 |
| Change (%) | -2.67% |
| Day's Open | 0.1500 |
| Day's Range | 0.1230 - 0.1500 |
| Day's Volume | 5,512 |
| 52-Week Range | 0.0115 - 0.19 |
News
There are no news available yet.
About BGMD
BG Medicine engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Feb 4, 2011 |
| CEO Paul Sohmer | Employees 5 |
| Stock Exchange OTCMKTS | Ticker Symbol BGMD |